Late-onset episodic ataxia associated with SLC1A3 mutation

Area of Science:

• Neurogenetics
• Molecular Neurology

Background:

• Episodic ataxia type 6 (EA6) is linked to mutations in SLC1A3, encoding the excitatory amino acid transporter 1 (EAAT1).
• EAAT1 is crucial for clearing synaptic glutamate and functions as an anion channel, regulating neuronal signaling.
• Dysfunction of EAAT1 can disrupt glutamate homeostasis, potentially leading to neurological deficits.

Purpose of the Study:

• To identify the genetic cause of episodic ataxia in a family with late-onset symptoms.
• To characterize a novel mutation in SLC1A3 and its potential impact on EAAT1 function.
• To expand the understanding of the genetic basis and clinical spectrum of EA6.

Main Methods:

• Whole-exome sequencing was performed to identify genetic variants in the affected family.
• A specific heterozygous missense mutation (c.1177G>A) in SLC1A3 was identified in the proband.
• The identified mutation was analyzed for its presence in affected and unaffected family members and compared against control databases.

Main Results:

• A novel heterozygous missense mutation, c.1177G>A, in SLC1A3 was identified in a family with episodic ataxia.
• This mutation results in an isoleucine substitution for a conserved valine residue in the EAAT1 protein's transmembrane domain.
• The mutation was found in affected individuals and some asymptomatic carriers, suggesting incomplete penetrance or variable expressivity.

Conclusions:

• The study expands the known mutation spectrum of SLC1A3 in EA6.
• A novel mutation in SLC1A3 contributes to the clinical phenotype of episodic ataxia, including late-onset presentation.
• These findings enhance the diagnostic and research landscape for EA6 and related channelopathies.